News AbbVie joins BMS in taking a hard line on UK drug pricing AbbVie has said it may not launch its ovarian cancer therapy Elahere in the UK if a viable NHS price cannot be agreed with NICE.
News BMS says it will set Cobenfy's UK price the same as the US Bristol Myers Squibb's price tag for schizophrenia drug Cobenfy in the UK is a manifestation of Trump's most favoured nation drug pricing policy.
News Imfinzi becomes first NHS drug for aggressive lung cancer AstraZeneca's PD-L1 inhibitor Imfinzi is the first drug therapy to be recommended for routine NHS use in limited-stage small cell lung cancer.
News NHS trust league tables arrive in UK health shakeup League tables for NHS trusts will end the postcode lottery of care, says the government, but not all are convinced.
News Uni wins big NIHR grant for healthtech 'horizon scanning' A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.
News UK adds chickenpox to childhood vaccination schedule The UK will offer free vaccination against chickenpox to young children from the start of 2026, in the hope of eliminating cases in a couple of years.
News Lilly's 'triple G' retatrutide aces crucial obesity trial Lilly's retatrutide achieved weight loss of more than 30% at two years in a new trial, firming up its credentials as a next-generation obesity drug.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
